Awarded Shanti Swarup Bhatnagar Award Biology 1998
Elected Fellow of the Indian Academy of Sciences, Bangalore 2007
Elected Fellow of the National Academy of Sciences, Allahabad, 1994
Elected Member of Guha Research Conference, 1994
Served as Head, Dean, Academic Council Member, Excecutive Council Member of Delhi University
Recipient of Bimal K Bachhawat Memorial Lecture Award of the National Academy of Sciences, Allahabad, 2011
Elected Fellow of the West Bengal Academy of Science & Technology (WAST), December 2011.
Selected for delivering the Platinum Jubilee Lecture in the Section of New Biology (including Biochemistry, Biophysics & Molecular Biology and Biotechnology) at the 102nd Indian Science Congress to be held at University of Mumbai, Mumbai during January 3-7, 2015.
Awarded a Gold Medal from the Banaras Hindu University for standing first in the M.Sc. (Biochemistry) examination in 1980.
International Union Against Cancer (Switzerland).
Biophysical Society (USA).
The New York Academy of Sciences (USA, By Invitation).
Molecular Immunology Forum (India, Elected)
Co-Convenor CSIR/UGC NET Examination Board
Expert Member of the task force of “Animal Science Committee”, CSIR
Elected Member, NII Finance Committee
Panel of Expert in National Institute of Biologicals, Noida
Elected Member Sectional Committee X, INSA, New Delhi w.e.f. 1st January 2014
Expert Member, DBT task force, IYBA
Member, Advisory Committee, School of Biotechnology, JNU
Elected Member Sectional Committee “General Biology”, Indian Academy of Sciences, Bangalore, wef. 1st January, 2016
Virosome technology has been licensed to the Panacea Biotech Ltd., New Delhi, through NRDC, NEW DELHI, MoU signed, March, 2002. Technology transfer process has been completed and one time Royalty (Rs. 25 Lakhs) received by University of Delhi. As of now, commercialization is awaited.
An active collaboration (preclinical studies with a Gunn rat model, supported jointly by NRDC, New Delhi and AECOM, USA) is going on since June, 2006 with Prof. Jayanta Roy-Chowdhury, for treating jaundice (Crigler-Najjar Syndrome, Type I Jaundice) with Sendai virus based F-virosome entrapped bilirubin-UDP glucouronysyl transferase (BUGT) gene to liver cells. Studies are completed (published in the Hepatology, Sept, 2009 issue) and based on the results, a PCT application has been filed and accepted in 2011.